Status:
UNKNOWN
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
Lead Sponsor:
University of Vermont
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
Thrombosis is common and contributes significantly to morbidity and mortality in patients with cancer. At least 20% of patients with cancer develop venous thromboembolism (VTE) and another 5% will exp...
Eligibility Criteria
Inclusion
- Active cancer diagnosis receiving cancer directed therapy
- Willing to consent to participation
Exclusion
- unwilling to provide informed consent,
- clinical or study physician declines patient enrollment.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05240508
Start Date
January 1 2022
End Date
December 31 2024
Last Update
May 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont Medical Center
Burlington, Vermont, United States, 05401